Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07311434 · ClinicalTrials.gov registry record · NA

Sleep and Morning Wellbeing Study

A NA study of Stress and Sleep, sponsored by Athletic Greens International.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT07311434: Recruiting NA study of Stress and Sleep, sponsored by Athletic Greens International.

NCT07311434 is a NA study of Stress and Sleep that is actively recruiting participants, run by Athletic Greens International. The registered enrollment target is 300 participants, below the 784-participant average among 152 other Stress trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07311434, a NA study of Stress and Sleep, is actively recruiting participants, sponsored by Athletic Greens International.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

The study will be a prospective randomized, controlled clinical study. There will be interventional treatment for a total of 30 days. The subjects will complete questionnaires throughout the study at pre-specified timepoints.

Primary Outcome

Assessed by subjective questionnaire

Interventions

  • DIETARY_SUPPLEMENT Sleep Supplement

Study Locations (1)

California

  • Alethios (Virtual Study Platform) - San Francisco

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2026-01-20
Est. Completion 2026-06-01
Phase NA
Athletic Greens International

8 total trials

What NCT07311434 shows while recruiting

NCT07311434 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 784-participant average among 152 other Stress trials with a reported enrollment target (62% lower).

The record links to 4 conditions, with Stress appearing as the primary indexed condition, and to 1 intervention - of which Sleep Supplement is the first listed.

NCT07311434 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT07311434 about?

NCT07311434 is a clinical study titled "Sleep and Morning Wellbeing Study". The study will be a prospective randomized, controlled clinical study. There will be interventional treatment for a total of 30 days. The subjects will complete questionnaires throughout the study at pre-specified timepoints.

What is the current status of trial NCT07311434?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2026-01-20. Estimated completion is 2026-06-01.

What conditions does trial NCT07311434 study?

This clinical trial studies the following conditions: Stress, Sleep, Relaxation, Daytime Sleepiness.

What interventions are being tested in trial NCT07311434?

The interventions under investigation include: Sleep Supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07311434?

This trial is sponsored by Athletic Greens International, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07311434 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07311434's enrollment target sits among peer trials

300 19th of 152 higher than 132 of 152 other Stress trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07311434, the US trial registry maintained by the National Library of Medicine. NCT07311434 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.